Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 50, Issue 4, 2001, Pages 477-480

  Taniguchi, Ataru ^a,b,c,d,e,f   Fukushima, Mitsuo ^a,b,c,d,e,f   Sakai, Masahiko ^a,b,c,d,e,f   Tokuyama, Kumpei ^a,b,c,d,e,f   Nagata, Itaru ^a,b,c,d,e,f   Fukunaga, Akiko ^a,b,c,d,e,f   Kishimoto, Hiroyuki ^a,b,c,d,e,f   Doi, Kentaro ^a,b,c,d,e,f   Yamashita, Yukio ^a,b,c,d,e,f   Matsuura, Toshifumi ^a,b,c,d,e,f   Kitatani, Naomi ^a,b,c,d,e,f   Okumura, Takahide ^a,b,c,d,e,f   Nagasaka, Shoichiro ^a,b,c,d,e,f   Nakaishi, Shigeo ^a,b,c,d,e,f   Nakai, Yoshikatsu ^a,b,c,d,e,f  

^a KANSAI DENRYOKU HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JICHI MEDICAL UNIVERSITY   (Japan)

^f Nakaishi Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC DIET; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; JAPAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0035048276     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.21028     Document Type: Article

References (30)

1. Lilly Lecture 1987: The triumvirate: Beta-cell, muscle, liver: A collusion responsible for NIDDM
2. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity
3. Pathogenic factors responsible for glucose intolerance in patients with NIDDM
4. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach
5. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance
6. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients
7. Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients
8. Insulin-sensitive and insulin-resistant variants in nonobese Japanese type 2 diabetic patients. The role of triglycerides in insulin resistance
9. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM
10. Bezafibrate reduces blood glucose in type 2 diabetes mellitus
11. Improvement of glucose tolerance in NIDDM by clofibrate: Randomized double-blind study
12. Evaluation of three total cholesterol methods
13. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man
14. Assessment of insulin sensitivity and insulin secretion from the OGTT in nonobese Japanese type 2 diabetic patients: Comparison with minimal model approach
15. Insulin sensitivity, insulin secretion, and glucose effectiveness in obese subjects: A minimal model analysis
16. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: The Insulin Resistance Atherosclerosis Study
17. Do blacks with NIDDM have an insulin-resistance syndrome?
18. Toward physiological understanding of glucose tolerance: Minimal-model approach
19. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis
20. Insulin and hypertriglyceridemia
21. Diminished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia
22. Effect of physical training on insulin sensitivity in Japanese type 2 diabetic patients: Role of serum triglyceride level
23. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas
24. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Studies in subjects with various degrees of glucose tolerance and insulin sensitivity
25. Homeostasis model assessment as a clinical index of insulin resistance: Comparison with them minimal model analysis
26. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
27. Assessment of insulin secretion from the oral glucose tolerance test in white patients with type 2 diabetes
28. The homeostasis model (HOMA) in Mexican Americans and non-Hispanic whites in the San Antonio Heart Study
29. Thazolidinediones: An update